Wells Fargo’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $4.53M | Buy |
|
|||||
|
2025
Q1 | $3.13M | Sell |
|
|||||
|
2024
Q4 | $3.55M | Sell |
|
|||||
|
2024
Q3 | $6.17M | Buy |
|
|||||
|
2024
Q2 | $3.06M | Buy |
|
|||||
|
2024
Q1 | $2.46M | Buy |
|
|||||
|
2023
Q4 | $2.27M | Sell |
|
|||||
|
2023
Q3 | $2.66M | Sell |
|
|||||
|
2023
Q2 | $3.54M | Buy |
|
|||||
|
2023
Q1 | $2.03M | Buy |
|
|||||
|
2022
Q4 | $397K | Sell |
|
|||||
|
2022
Q3 | $629K | Sell |
|
|||||
|
2022
Q2 | $511K | Sell |
|
|||||
|
2022
Q1 | $2.67M | Sell |
|
|||||
|
2021
Q4 | $6.95M | Sell |
|
|||||
|
2021
Q3 | $8.55M | Buy |
|
|||||
|
2021
Q2 | $7.17M | Sell |
|
|||||
|
2021
Q1 | $9M | Buy |
|
|||||
|
2020
Q4 | $6.94M | Buy |
|
|||||
|
2020
Q3 | $4.09M | Sell |
|
|||||
|
2020
Q2 | $4.25M | Buy |
|
|||||
|
2020
Q1 | $2.63M | Buy |
|
|||||
|
2019
Q4 | $2.92M | Sell |
|
|||||
|
2019
Q3 | $3.09M | Buy |
|
|||||
|
2019
Q2 | $3.89M | Buy |
|
|||||
|
2019
Q1 | $2.73M | Buy |
|
|||||
|
2018
Q4 | $1.79M | Buy |
|
|||||
|
2018
Q3 | $2.55M | Buy |
|
|||||
|
2018
Q2 | $1.26M | Sell |
|
|||||
|
2018
Q1 | $2.29M | Buy |
|
|||||
|
2017
Q4 | $1.82M | Sell |
|
|||||
|
2017
Q3 | $2.9M | Buy |
|
|||||
|
2017
Q2 | $1.46M | Buy |
|
|||||
|
2017
Q1 | $877K | Buy |
|
|||||
|
2016
Q4 | $439K | Buy |
|
|||||
|
2016
Q3 | $203K | Hold |
|
|||||
|
2016
Q2 | $139K | Buy |
|
|||||
|
2016
Q1 | $71K | Buy |
|
|||||
|
2015
Q4 | $84K | Sell |
|
|||||
|
2015
Q3 | $68K | Buy |
|
|||||
|
2015
Q2 | $12K | Buy |
|